Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

AASLD 2026 5 - 9 November 2026

Efruxifermin drives multidimensional histologic improvement in compensated cirrhosis: An AI-based analysis from the SYMMETRY randomized controlled trial

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.

Keywords

MASH

Congress oral presentation

Fibroblast growth factor

PHASE 2 (RCT)

Search Science Hub

Are you a healthcare professional?

Efruxifermin drives multidimensional histologic improvement in compensated cirrhosis: An AI-based analysis from the SYMMETRY randomized controlled trial​

Efruxifermin drives multidimensional histologic improvement in compensated cirrhosis: An AI-based analysis from the SYMMETRY randomized controlled trial